Laurel Wealth Advisors (North Carolina)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-229
Closed -$234 700
2024
Q2
$234 Buy
+229
New +$234 ﹤0.01% 624